Current Options for Systemic Therapy in Mesothelioma
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery
Reference63 articles.
1. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus, and Heart;Travis,2004
2. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems;Edwards;Thorax,2000
3. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B;Herndon;Chest,1998
4. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma;van Klaveren;Lung Cancer,2004
5. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma;Byrne;Ann Oncol,2004
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An assistive concrete blended modeling technique for mesothelioma disease prediction using machine learning;PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ENGINEERING RESEARCH AND APPLICATION 2022 (ICERA 2022);2023
2. Application of IPC, HIPEC, and PIPAC;Peritoneal Tumors and Metastases;2021
3. The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy;Anticancer Research;2019-11
4. Applikation von IPC, HIPEC und PIPAC;Peritoneale Tumoren und Metastasen;2018
5. Comparison of the Efficacy and Safety of Pemetrexed-Based Versus Paclitaxel-Based Chemotherapy as Third-Line Treatment for Patients with Advanced Breast Cancer;J INT TRANSL MED;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3